Yashraj Biotechnology Revenue and Competitors

Mumbai, IND

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Yashraj Biotechnology's estimated annual revenue is currently $21.2M per year.(i)
  • Yashraj Biotechnology's estimated revenue per employee is $77,500

Employee Data

  • Yashraj Biotechnology has 273 Employees.(i)
  • Yashraj Biotechnology grew their employee count by 8% last year.

Yashraj Biotechnology's People

NameTitleEmail/Phone
1
Senior ManagerReveal Email/Phone
2
ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M155-4%N/AN/A
#2
$17.3M22318%N/AN/A
#3
$11.1M14334%N/AN/A
#4
$8.2M1068%N/AN/A
#5
$9.5M12310%N/AN/A
#6
$21.2M2738%N/AN/A
#7
$12M1558%N/AN/A
#8
$18.9M2445%N/AN/A
#9
$12.5M1619%N/AN/A
#10
$20.5M2648%N/AN/A
Add Company

What Is Yashraj Biotechnology?

Yashraj Biotech Ltd. manufactures a wide range of high pure biomarkers in the form of native and recombinant proteins that are used by the diagnostic industry as controls, calibrators and immunogen. YBL has been the preferred partner of most of the top 20 diagnostic companies around the world for the past 15 years. Our state of the art manufacturing facility in Mumbai, India, with branch offices in Germany and USA offers ISO 13485 and ISO 9001 standard native proteins from diverse range of biomedical fluid such as cancer fluid, disease infected blood, pleural and ascetic fluid, seminal plasma, renal failure urine and cerebrospinal fluid which helps in developing new biomarkers and ensuring bulk availability at shortest lead time. Come and join us at Yashraj Biotechnology Ltd. in our quest to make diagnostics more affordable and accessible.

keywords:N/A

N/A

Total Funding

273

Number of Employees

$21.2M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Yashraj Biotechnology News

2022-04-19 - Pune health matters: RSSDI gets new chairperson; ‘time lapse imaging Embryoscope’ machine for fertility treatment launched at DPU

... Imaging technology increases the chances of pregnancy, Dr Yashraj Patil, ... by the Indian biotechnology company, Regrow Biosciences.

2022-02-22 - Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report ...

VistaGen Therapeutics, Inc. Waisman Biomanufacturing; xCell Science, Inc. Yashraj Biotechnology, Ltd. For more information about this report...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.5M2738%$2M
#2
$31.6M274-20%N/A
#3
N/A27428%N/A
#4
$30.3M27421%N/A
#5
$27.2M275-15%N/A